Delivery Order SPE2DE21D7020-SPE2D626F7542
Award Date 10/30/25
Potential Completion Date 11/6/25
Potential Value $6.7K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed Pricing Type
Fixed Price with Economic Price Adjustment
Place of Performance
Marlborough, MA 01752, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Boston Scientific Corp, a leading global medical technology company headquartered in Marlborough, Massachusetts, was awarded a delivery order valued at $6,652.60 for enroute TCAR stents on September 26, 2025, with an ultimate completion date of October 3, 2025. This fixed-price contract with economic price adjustment was issued by the Defense Health Agency's Medical Supply Chain division and will be performed in Marlborough, MA. The contract represents no set-aside designation, allowing Boston...
- Boston Scientific Corp, a leading global medical technology company headquartered in Marlborough, Massachusetts, was awarded a delivery order valued at $7,593.10 for EnRoute TCAR stents on August 14, 2025. This fixed-price contract with economic price adjustment is scheduled for ultimate completion by August 21, 2025, and will be performed at Boston Scientific's Marlborough facility. The award is being funded through the Defense Health Agency's Medical Supply Chain, a defense-focused federal...
- Boston Scientific Corp, headquartered in Marlborough, Massachusetts, was awarded a fixed-price delivery order valued at $7,593.10 by the Defense Health Agency's Medical Supply Chain on August 20, 2025, with an ultimate completion date of August 27, 2025. The contract involves the supply of enroute TCAR (transcarotid artery revascularization) stents, specialized cardiovascular intervention devices used in minimally invasive procedures. This delivery order was competitively awarded with no...
- Boston Scientific Corp was awarded a delivery order valued at $3,326.30 by the Defense Health Agency's Medical Supply Chain for enroute TCAR stents, with performance in Marlborough, MA. The contract was awarded on August 12, 2025, with an ultimate completion date of August 19, 2025, and utilizes fixed-price pricing with economic price adjustment. This is an open competition award with no set-aside designation, allowing Boston Scientific to compete directly against other qualified vendors in...
- Boston Scientific Corp has been awarded a delivery order valued at $11,389.65 for enroute TCAR stents under a Defense Health Agency Medical Supply Chain contract. The award, issued on September 2, 2025, with an ultimate completion date of September 9, 2025, represents a fixed-price contract with economic price adjustment provisions. The work will be performed at Boston Scientific's facility in Marlborough, Massachusetts. No set-aside designation was applied to this award, indicating open...
- Boston Scientific Corp, a leading global medical technology company headquartered in Marlborough, Massachusetts, was awarded a $5,447.25 delivery order by the Defense Health Agency's Medical Supply Chain for an Enroute Transcarotid Neuroprotection System with a completion date of October 21, 2025. This fixed-price contract with economic price adjustment features no set-aside designation, allowing Boston Scientific to compete openly in the federal marketplace. The award reflects the company's...
- The Defense Health Agency's Medical Supply Chain awarded a delivery order valued at $3,326.30 to Boston Scientific Corp for EnRoute TCAR stents on July 25, 2025, with an ultimate completion date of August 1, 2025. This fixed-price contract with economic price adjustment carries no set-aside designation, allowing Boston Scientific to compete openly in the federal marketplace. The work will be performed at Boston Scientific's facility in Marlborough, Massachusetts, where the company manufactures...
- Boston Scientific Corp, a global medical technology company headquartered in Marlborough, Massachusetts, has been awarded a delivery order valued at $3,010.72 for wallstents under the Defense Health Agency's Medical Supply Chain program. The contract, awarded on August 11, 2025, with an ultimate completion date of August 18, 2025, utilizes fixed-price pricing with economic price adjustment. This delivery order represents part of Boston Scientific's broader federal portfolio, which encompasses...
- The U.S. Department of Veterans Affairs, Veterans Integrated Service Network 4, awarded a delivery order valued at $52,168.93 to Boston Scientific Corp for an Emergency Enroute Transcarotid Neuroprotection System. The contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating open competition. Performance will occur in Pittsburgh, Pennsylvania, with a completion date of December 31, 2028. Boston Scientific, a global medical technology company...
- This is a federal contract award to Boston Scientific Corp, a global medical technology company, by the Defense Health Agency (DHA) for the delivery of ENROUTE TCAR stents. The contract is a Delivery Order with a Fixed Price with Economic Price Adjustment pricing type, and a ceiling value of $3,796.55. The contract does not have a set-aside designation. The performance period extends to June 10, 2025. Boston Scientific is also the holder of two federal Indefinite Delivery Vehicles (IDVs) with...